相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia
V. El-Khoury et al.
LEUKEMIA (2014)
Modulation of apoptosis sensitivity through the interplay with autophagic and proteasomal degradation pathways
M. E. Delgado et al.
CELL DEATH & DISEASE (2014)
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Rongqing Pan et al.
CANCER DISCOVERY (2014)
Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells
Maria Lyngaas Torgersen et al.
BLOOD (2013)
New Strategies in the Treatment of Multiple Myeloma
Nikhil C. Munshi et al.
CLINICAL CANCER RESEARCH (2013)
U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
Thomas M. Herndon et al.
CLINICAL CANCER RESEARCH (2013)
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer
Rebekah L. Zinn et al.
MOLECULAR CANCER (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor
Anna V. Miller et al.
PLOS ONE (2013)
The Sensitivity of Diffuse Large B-Cell Lymphoma Cell Lines to Histone Deacetylase Inhibitor-Induced Apoptosis Is Modulated by BCL-2 Family Protein Activity
Ryan C. Thompson et al.
PLOS ONE (2013)
Mitochondria: gatekeepers of response to chemotherapy
Kristopher A. Sarosiek et al.
TRENDS IN CELL BIOLOGY (2013)
Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma
G. M. Matthews et al.
CELL DEATH & DISEASE (2013)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky et al.
AUTOPHAGY (2012)
Romidepsin for Cutaneous T-cell Lymphoma
H. Miles Prince et al.
CLINICAL CANCER RESEARCH (2012)
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
Omar Khan et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
Rekha Rao et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Bim Inhibits Autophagy by Recruiting Beclin 1 to Microtubules
Shouqing Luo et al.
MOLECULAR CELL (2012)
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S. K. Kumar et al.
LEUKEMIA (2012)
Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death
Noor Gammoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
ABT-737 is highly effective against molecular subgroups of multiple myeloma
Linda Bodet et al.
BLOOD (2011)
Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
Alejo A. Morales et al.
BLOOD (2011)
Autophagy as a target for anticancer therapy
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy
Dian J. Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Priming Cancer Cells for Death
John C. Reed
SCIENCE (2011)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma
Dharminder Chauhan et al.
BLOOD (2010)
IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms
Elke De Bruyne et al.
BLOOD (2010)
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Derek Yecies et al.
BLOOD (2010)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
Laura Bonapace et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The BCL-2 Family Reunion
Jerry E. Chipuk et al.
MOLECULAR CELL (2010)
BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program
Decheng Ren et al.
SCIENCE (2010)
Integration of Clearance Mechanisms: The Proteasome and Autophagy
Esther Wong et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors
Kate F. Whitecross et al.
BLOOD (2009)
The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma
Mathilde Romagnoli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Involvement of BH3-only proteins in hematologic malignancies
Junya Kuroda et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics
Annette S. Gillings et al.
FEBS JOURNAL (2009)
Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1
Shuang Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
A Role for Ubiquitin in Selective Autophagy
Vladimir Kirkin et al.
MOLECULAR CELL (2009)
LAMP-2 - A control step for phagosome and autophagosome maturation
Paul Saftig et al.
AUTOPHAGY (2008)
Bcl-2 family members - Dual regulators of apoptosis and autophagy
Beth Levine et al.
AUTOPHAGY (2008)
Multisite phosphorylation regulates Bim stability and apoptotic activity
Anette Hubner et al.
MOLECULAR CELL (2008)
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis
K. Podar et al.
ONCOGENE (2008)
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents
Jing Deng et al.
CANCER CELL (2007)
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells
M. P. Kline et al.
LEUKEMIA (2007)
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
Jennifer S. Carew et al.
BLOOD (2007)
Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1
M. Chiara Maiuri et al.
EMBO JOURNAL (2007)
A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
D. Chauhan et al.
ONCOGENE (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons
R Meller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex
P Gomez-Bougie et al.
ONCOGENE (2005)
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
S Pattingre et al.
CELL (2005)
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma
TE Fandy et al.
NEOPLASIA (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Subversion of cellular autophagosomal machinery by RNA viruses
WT Jackson et al.
PLOS BIOLOGY (2005)
BH3 domains of BH3-only proteins differentially regulate bax-mediated mitochondrial membrane permeabilization both directly and indirectly
T Kuwana et al.
MOLECULAR CELL (2005)
Inhibition of macroautophagy triggers apoptosis
P Boya et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells
P Gomez-Bougie et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells
YN Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
R Ley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism
Y Dai et al.
BLOOD (2002)
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
PA Marks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
